E11.37 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Short description for E11.37 ICD 10 code:
Type 2 diab with diabetic macular edema, resolved fol trtmt
Codes
- E11.37X1 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye
- E11.37X2 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye
- E11.37X3 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral
- E11.37X9 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye
Possible back-references that may be applicable or related to E11.37 ICD10 Code:
- E00-E89 Endocrine, nutritional and metabolic diseases
- E08-E13 Diabetes mellitus
- E11 Type 2 diabetes mellitus
- E11.0 Type 2 diabetes mellitus with hyperosmolarity
- E11.1 Type 2 diabetes mellitus with ketoacidosis
- E11.2 Type 2 diabetes mellitus with kidney complications
- E11.3 Type 2 diabetes mellitus with ophthalmic complications
- E11.4 Type 2 diabetes mellitus with neurological complications
- E11.5 Type 2 diabetes mellitus with circulatory complications
- E11.6 Type 2 diabetes mellitus with other specified complications
Present On Admission (POA Exempt)
E11.37 ICD 10 code is considered exempt from POA reporting
Clinical information about E11.37 ICD 10 code
Type 2 diabetes is a disorder characterized by abnormally high levels of blood glucose, also called blood sugar. In this form of diabetes, the body stops using and making insulin properly. Insulin is a hormone produced in the pancreas that helps regulate blood glucose levels. Specifically, insulin controls how much glucose (a type of sugar) is passed from the blood into cells, where it is used as an energy source. When blood glucose levels are high (such as after a meal), the pancreas releases insulin to move the excess glucose into cells, which reduces the amount of glucose in the blood.
Most people who develop type 2 diabetes first have insulin resistance, a condition in which the body's cells use insulin less efficiently than normal. As insulin resistance develops, more and more insulin is needed to keep blood glucose levels in the normal range. To keep up with the increasing need, insulin-producing cells in the pancreas (called beta cells) make larger amounts of insulin. Over time, the beta cells become less able to respond to blood glucose changes, leading to an insulin shortage that prevents the body from reducing blood glucose levels effectively. Most people have some insulin resistance as they age, but inadequate exercise and excessive weight gain make it worse, greatly increasing the likelihood of developing type 2 diabetes.
Type 2 diabetes can occur at any age, but it most commonly begins in middle age or later. Signs and symptoms develop slowly over years. They include frequent urination (polyuria), excessive thirst (polydipsia), fatigue, blurred vision, tingling or loss of feeling in the hands and feet (diabetic neuropathy), sores that do not heal well, and weight loss. If blood glucose levels are not controlled through medication or diet, type 2 diabetes can cause long-lasting (chronic) health problems including heart disease and stroke; nerve damage; and damage to the kidneys, eyes, and other parts of the body.
The information in this box was provided by MedlinePlus.gov